Elisa Roldán

870 total citations
18 papers, 97 citations indexed

About

Elisa Roldán is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Elisa Roldán has authored 18 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Elisa Roldán's work include Hematopoietic Stem Cell Transplantation (5 papers), Neutropenia and Cancer Infections (3 papers) and Acute Myeloid Leukemia Research (2 papers). Elisa Roldán is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Neutropenia and Cancer Infections (3 papers) and Acute Myeloid Leukemia Research (2 papers). Elisa Roldán collaborates with scholars based in Spain, United Kingdom and Italy. Elisa Roldán's co-authors include David Valcárcel, Francesc Bosch, Pere Barba, Isabel Ruíz-Camps, Benito Almirante, Margarita Ortega, Fernando Martínez‐Valle, Marı́a Gómez, Guillermo Villacampa and Josep Castellví and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Neurology.

In The Last Decade

Elisa Roldán

17 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Roldán Spain 6 47 22 21 21 17 18 97
Guillaume Morelle France 6 61 1.3× 14 0.6× 63 3.0× 15 0.7× 19 1.1× 8 120
Micha Srour France 7 43 0.9× 26 1.2× 14 0.7× 33 1.6× 18 1.1× 27 112
Eva Bubanská Slovakia 7 34 0.7× 21 1.0× 28 1.3× 30 1.4× 27 1.6× 13 110
Maja Klaudel‐Dreszler Poland 7 27 0.6× 13 0.6× 66 3.1× 13 0.6× 23 1.4× 24 123
Milena Kohn France 5 42 0.9× 19 0.9× 31 1.5× 26 1.2× 3 0.2× 9 81
Clémence Mediavilla France 8 88 1.9× 10 0.5× 26 1.2× 31 1.5× 27 1.6× 18 137
Reem Mohammed Saudi Arabia 7 27 0.6× 18 0.8× 85 4.0× 10 0.5× 17 1.0× 14 137
Nicholas M. Murphy Australia 7 29 0.6× 41 1.9× 28 1.3× 16 0.8× 18 1.1× 15 130
Firoozeh Sahebi United States 7 90 1.9× 12 0.5× 34 1.6× 29 1.4× 13 0.8× 14 120
Arina Lazareva United Kingdom 5 55 1.2× 9 0.4× 27 1.3× 52 2.5× 26 1.5× 10 108

Countries citing papers authored by Elisa Roldán

Since Specialization
Citations

This map shows the geographic impact of Elisa Roldán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Roldán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Roldán more than expected).

Fields of papers citing papers by Elisa Roldán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Roldán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Roldán. The network helps show where Elisa Roldán may publish in the future.

Co-authorship network of co-authors of Elisa Roldán

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Roldán. A scholar is included among the top collaborators of Elisa Roldán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Roldán. Elisa Roldán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Boffa, Giacomo, Angela Genchi, Alice Mariottini, et al.. (2025). Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. Multiple Sclerosis Journal. 31(12). 1401–1416.
2.
Brittain, Gavin, Elisa Roldán, Tobias Alexander, et al.. (2024). The Role of Chimeric Antigen Receptor T‐Cell Therapy in Immune‐Mediated Neurological Diseases. Annals of Neurology. 96(3). 441–452. 7 indexed citations
3.
García‐Cadenas, Irene, Isabel Sánchez‐Ortega, Francesc Fernández‐Avilés, et al.. (2022). Low Rate of Infectious Enterocolitis in Allogeneic Stem Cell Transplant Recipients with Acute Diarrhea: A Prospective Study by the GETH-TC. Acta Haematologica. 146(2). 161–165. 1 indexed citations
4.
Barba, Pere, Elisa Roldán, María Suárez‐Lledó, et al.. (2022). Viral-Specific T Cell Therapy for Cytomegalovirus Infection after Stem Cell Transplantation and Generation of a Third-Party T-Cell Donor Registry. Blood. 140(Supplement 1). 10309–10310. 2 indexed citations
5.
Brittain, Gavin, Alasdair Coles, Gavin Giovannoni, et al.. (2022). Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why?. Practical Neurology. 23(2). 139–145. 4 indexed citations
6.
Cortellini, Alessio, Elisa Roldán, Margarita García, et al.. (2021). 1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection. Annals of Oncology. 32. S1130–S1130. 3 indexed citations
7.
Díaz‐Lagares, Cándido, María Laura Fox, Manel M. Santafé, et al.. (2021). Sequential Organ Failure Assessment Score and the Need for Organ Support Predict Mortality in Allogeneic Stem Cell Transplant Patients Admitted to the Intensive Care Unit. Transplantation and Cellular Therapy. 27(10). 865.e1–865.e7. 6 indexed citations
8.
Fox, María Laura, Irene García‐Cadenas, Ariadna Pérez, et al.. (2020). Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis. Leukemia & lymphoma. 61(8). 1823–1832. 2 indexed citations
9.
Albasanz‐Puig, Adaia, Dolors Rodríguez-Pardo, Carles Pigrau, et al.. (2020). Necrotizing fasciitis in haematological patients: a different scenario. Annals of Hematology. 99(8). 1741–1747. 8 indexed citations
10.
Roldán, Elisa, Miguel‐Angel Perales, & Pere Barba. (2019). Allogeneic Stem Cell Transplantation with CD34+ Cell Selection. SHILAP Revista de lepidopterología. 1(3). 154–160. 3 indexed citations
11.
Gómez, Marı́a, et al.. (2019). Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study. Mycoses. 62(9). 765–772. 15 indexed citations
12.
Gallur, Laura, Elisa Roldán, Fernando Martínez‐Valle, et al.. (2018). Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes. Annals of Hematology. 97(8). 1349–1356. 32 indexed citations
13.
Pomares, Helena, Guillermo Villacampa, Esther Alonso, et al.. (2018). Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes. Leukemia & lymphoma. 60(6). 1522–1527. 1 indexed citations
15.
Bosch, Anna, Irene García‐Cadenas, Elisa Roldán, et al.. (2018). Usefulness of thrombopoietin receptor agonists for persistent clinically relevant thrombocytopenia after allogeneic stem cell transplantation. European Journal Of Haematology. 101(3). 407–414. 8 indexed citations
16.
17.
Muñoz, Alvaro, et al.. (1993). [Allogenic bone marrow transplantation in Wiskott-Aldrich syndrome].. PubMed. 101(7). 258–60. 1 indexed citations
18.
Moral, Ana del, et al.. (1989). Formation of Bobierrite (Magnesium Phosphate) Crystal Aggregates by Bacteria from Human Urine and Renal Calculi. Urologia Internationalis. 44(4). 222–226. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026